Analysts, who are highly bullish on the stock, have fretted for some time that Viking needed a partner to actually make the ...

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

Viking Holdings Ltd. is banking on affluent customers to see it through this period of jitters in the travel industry.While ...

Goldman Sachs analyst Lizzie Dove reiterated a Neutral rating on the shares of Viking Holdings Ltd (NYSE:VIK) and raised the ...

Viking Cruises' unique ship designs, being small and almost identical, set the company apart and serve as an important value ...

Less than a year after CordenPharma earmarked a major chunk of change to beef up in peptide manufacturing for GLP-1s and ...

Viking announced a supply deal with CordenPharma that sets it up for a standalone path to the obesity market. Read why I ...

VIKING NEBULA shows what happens when military operation planners try to come up with a good mission name, unlike Odyssey Dawn.

Viking Holdings (NYSE:VIK) reports robust Q4 growth with a 20.5% sales surge and plans to expand in 2025. Discover key ...

Today, Benzinga's options scanner spotted 8 options trades for Viking Therapeutics. This is not a typical pattern. The ...

CordenPharma, a CDMO focused on peptides and peptide-based therapeutics, announced a partnership with Viking Therapeutics. The two companies will work together to ensure the production of Viking’s GLP ...

The biotech will commit $150 million to an alliance that hands it significant production capacity for a closely watched ...